Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigenic peptides deriving from secretogranin V and uses thereof for the diagnosis and treatment of type 1 diabetes

Antigenic peptides deriving from secretogranin V and uses thereof for the diagnosis and treatment of type 1 diabetes

US Patent 12492230 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis 2024
Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis 2024
Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis 2024
Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis 2024
Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis 2024
T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabe2021
T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabe2021
Method to manufacture a throttle valve for an internal combustion engine provide2021
Methods and pharmaceutical compositions for inducing immune tolerance by mucosal2019
Throttle valve for an internal combustion engine provided with a conditioning ci2019
Electromechanical actuator for an internal combustion engine provided with a con2018
Methods for stimulating antigen-specific T cell responses2017